{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:35:55Z","timestamp":1793723755094,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AGRO1046543"],"award-info":[{"award-number":["AGRO1046543"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["PTCG-20\\u2013700751"],"award-info":[{"award-number":["PTCG-20\\u2013700751"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.inpsyc.2025.100181","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:21:46Z","timestamp":1768076506000},"page":"100181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study"],"prefix":"10.1016","author":[{"given":"Krushnaa","family":"Sankhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myuri","family":"Ruthirakuhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Andreazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Brawman-Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-6110","authenticated-orcid":false,"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-502X","authenticated-orcid":false,"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-3638","authenticated-orcid":false,"given":"Jacobo","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad R.","family":"Padala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-1738","authenticated-orcid":false,"given":"Anton P.","family":"Porsteinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-2044","authenticated-orcid":false,"given":"Shankar","family":"Tumati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"van Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jalz.2016.05.008","article-title":"Apathy associated with neurocognitive disorders: recent progress and future directions","volume":"13","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.147.1.22","article-title":"Differential diagnosis and classification of apathy","volume":"147","author":"Marin","year":"1990","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.inpsyc.2025.100181_bib3","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/alz.12358","article-title":"Diagnostic criteria for apathy in neurocognitive disorders","volume":"17","author":"Miller","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.inpsyc.2025.100181_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.inpsyc.2025.100181_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1532-5415.2009.02680.x","article-title":"Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study","volume":"58","author":"Okura","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.inpsyc.2025.100181_bib6","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1017\/S1041610216000922","article-title":"A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being","volume":"28","author":"Feast","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.inpsyc.2025.100181_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.792168","article-title":"Apathy as a risky neuropsychiatric syndrome of progression from normal aging to mild cognitive impairment and dementia: a systematic review and meta-analysis","volume":"12","author":"Fan","year":"2021","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.inpsyc.2025.100181_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/jamapsychiatry.2018.1877","article-title":"Association of apathy with risk of incident dementia: a systematic review and meta-analysis","volume":"75","author":"van Dalen","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.inpsyc.2025.100181_bib9","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/jgs.15007","article-title":"Apathy: risk factor for mortality in nursing home patients","volume":"65","author":"Nijsten","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.inpsyc.2025.100181_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-2012-120913","article-title":"Apathy syndrome in Alzheimer\u2019s disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors","volume":"33","author":"Vilalta-Franch","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.inpsyc.2025.100181_bib11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/gps.1594","article-title":"The contribution of neuropsychiatric symptoms to the cost of dementia care","volume":"21","author":"Herrmann","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.inpsyc.2025.100181_bib12","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/alz.12915","article-title":"Apathy in patients with Alzheimer\u2019s disease is a cost-driving factor","volume":"19","author":"Kruse","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.inpsyc.2025.100181_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4236\/jbbs.2012.22031","article-title":"Biomarkers and depressive symptoms in older women with and without cognitive impairment","volume":"2","author":"Hall","year":"2012","journal-title":"J Behav Brain Sci"},{"issue":"4","key":"10.1016\/j.inpsyc.2025.100181_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1017\/S1041610214002683","article-title":"Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individuals","volume":"27","author":"Eurelings","year":"2015","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.inpsyc.2025.100181_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1590\/S1980-57642013DN70300011","article-title":"AL. Serum levels of soluble TNF-\u03b1 receptors but not BDNF are associated with apathy symptoms in mild Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"7","author":"Guimar\u00e3es","year":"2013","journal-title":"Dement Neuropsychol"},{"issue":"4","key":"10.1016\/j.inpsyc.2025.100181_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4236\/nm.2011.24040","article-title":"Biomarkers and depressive symptoms in a sample of cognitively intact and Alzheimer\u2019s disease elderly males","volume":"2","author":"Hall","year":"2011","journal-title":"Neurosci Med"},{"issue":"2","key":"10.1016\/j.inpsyc.2025.100181_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3233\/JAD-220274","article-title":"Lipid peroxidation as a marker of apathy and executive dysfunction in patients at risk for vascular cognitive impairment","volume":"89","author":"Bawa","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.inpsyc.2025.100181_bib18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2021.3356","article-title":"Effect of methylphenidate on apathy in patients With Alzheimer disease: the ADMET 2 randomized clinical trial","volume":"78","author":"Mintzer","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.inpsyc.2025.100181_bib19","unstructured":"FDA-NIH Biomarker Working Group. B.E.S.T. (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring (MD): Food and Drug Administration (US); 2016 [cited 2024 Jan 25]. Available from: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/\u3009."},{"key":"10.1016\/j.inpsyc.2025.100181_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13063-017-2406-5","article-title":"The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial","volume":"19","author":"Scherer","year":"2018","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.inpsyc.2025.100181_bib21","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.inpsyc.2025.100181_bib22","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.623","article-title":"The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation","volume":"7","author":"Chicco","year":"2021","journal-title":"PeerJ Comput Sci"},{"key":"10.1016\/j.inpsyc.2025.100181_bib23","unstructured":"R: The R Project for Statistical Computing [Internet]. [cited 2025 Nov 13]. Available from: \u3008https:\/\/www.r-project.org\/\u3009."},{"key":"10.1016\/j.inpsyc.2025.100181_bib24","unstructured":"Posit | The Open-Source Data Science Company [Internet]. Posit. [cited 2025 Nov 13]. Available from: \u3008https:\/\/posit.co\/\u3009."},{"issue":"4","key":"10.1016\/j.inpsyc.2025.100181_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/geriatrics8040075","article-title":"An update on apathy in Alzheimer\u2019s disease","volume":"8","author":"Dolphin","year":"2023","journal-title":"Geriatr (Basel)"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-215314","article-title":"Factors associated with apathy in Alzheimer\u2019s disease: a cross-sectional analysis of the texas Alzheimer\u2019s research and care consortium (TARCC) Study","volume":"86","author":"Teixeira","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.inpsyc.2025.100181_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0197-4580(01)00291-3","article-title":"The role of TNF and its receptors in Alzheimer\u2019s disease","volume":"22","author":"Collins","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"10","key":"10.1016\/j.inpsyc.2025.100181_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.inpsyc.2025.100181_bib29","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","article-title":"Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment","volume":"31","author":"Buchhave","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.inpsyc.2025.100181_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000000665","article-title":"Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife","volume":"83","author":"Singh-Manoux","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt24","article-title":"Inflammation in Alzheimer\u2019s disease: relevance to pathogenesis and therapy","volume":"2","author":"Zotova","year":"2010","journal-title":"Alzheimers Res Ther"},{"issue":"22","key":"10.1016\/j.inpsyc.2025.100181_bib32","first-page":"2109","article-title":"How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury","volume":"248","author":"Gayger-Dias","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"10.1016\/j.inpsyc.2025.100181_bib33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/13894501113149990014","article-title":"Serum S100B represents a new biomarker for mood disorders","volume":"14","author":"Schroeter","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.inpsyc.2025.100181_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pnpbp.2012.12.001","article-title":"Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone","volume":"43","author":"de Souza","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.inpsyc.2025.100181_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jneuroim.2006.12.011","article-title":"Autocrine S100B effects on astrocytes are mediated via RAGE","volume":"184","author":"Ponath","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.inpsyc.2025.100181_bib36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B\u2019s double life: intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.inpsyc.2025.100181_bib37","first-page":"83","article-title":"S100 B: a new concept in neurocritical care","volume":"16","author":"Rezaei","year":"2017","journal-title":"Iran J Neurol"},{"issue":"7","key":"10.1016\/j.inpsyc.2025.100181_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/jnr.21211","article-title":"A. S100B in neuropathologic states: the CRP of the brain?","volume":"85","author":"Sen","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.inpsyc.2025.100181_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-7-6","article-title":"Serum levels of S100B and NSE proteins in Alzheimer\u2019s disease patients","volume":"7","author":"Chaves","year":"2010","journal-title":"J Neuroinflamm"},{"issue":"9","key":"10.1016\/j.inpsyc.2025.100181_bib40","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/glia.23994","article-title":"Implication of cerebral astrocytes in major depression: a review of fine neuroanatomical evidence in humans","volume":"69","author":"O\u2019Leary","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.inpsyc.2025.100181_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91577-6","article-title":"Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders","volume":"11","author":"Rajewska-Rager","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.inpsyc.2025.100181_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0924-977X(03)00016-6","article-title":"S100B and response to treatment in major depression: a pilot study","volume":"13","author":"Arolt","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.inpsyc.2025.100181_bib45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.inpsyc.2025.100181_bib46","first-page":"1","article-title":"Oxidative stress markers predict treatment outcomes in patients with generalized anxiety disorder treated with selective serotonin reuptake inhibitors","author":"Cui","year":"2025","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.inpsyc.2025.100181_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.inpsyc.2025.100181_bib48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment","volume":"76","author":"Naude","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.inpsyc.2025.100181_bib49","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1601-183X.2012.00825.x","article-title":"Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice","volume":"11","author":"Huang","year":"2012","journal-title":"Genes Brain Behav"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.euroneuro.2011.04.003","article-title":"Methylphenidate administration determines enduring changes in neuroglial network in rats","volume":"22","author":"Cavaliere","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.inpsyc.2025.100181_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2019.101712","article-title":"Long-term administration of high-dose methylphenidate-induced cerebellar morphology and function damage in adult rats","volume":"103","author":"Raoofi","year":"2020","journal-title":"J Chem Neuroanat"},{"issue":"1","key":"10.1016\/j.inpsyc.2025.100181_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00702-016-1623-5","article-title":"Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats","volume":"124","author":"Motaghinejad","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.inpsyc.2025.100181_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1621767","article-title":"Novel hematologic ratios and systemic inflammation index in ADHD: effects of methylphenidate treatment","volume":"16","author":"Ka\u015fak","year":"2025","journal-title":"Front Psychiatry"},{"issue":"5","key":"10.1016\/j.inpsyc.2025.100181_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.inpsyc.2025.100074","article-title":"Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders","volume":"37","author":"Sankhe","year":"2025","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"10.1016\/j.inpsyc.2025.100181_bib55","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4088\/JCP.12m08099","article-title":"Safety and efficacy of methylphenidate for apathy in Alzheimer\u2019s disease: a randomized, placebo-controlled trial","volume":"74","author":"Rosenberg","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.inpsyc.2025.100181_bib56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1017\/S1041610222001089","article-title":"Apathy and depression in mild cognitive impairment: distinct longitudinal trajectories and clinical outcomes","volume":"35","author":"Connors","year":"2023","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.inpsyc.2025.100181_bib57","article-title":"Understanding the role of neuropsychiatric symptoms in functional decline in Alzheimer\u2019s disease","author":"Zhu","year":"2025","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.inpsyc.2025.100181_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.inpsyc.2025.100089","article-title":"Apathy is distinct from depression or fatigue and is associated with poor physical health in an older community cohort","volume":"37","author":"Harrison","year":"2025","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.inpsyc.2025.100181_bib59","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3233\/JAD-140849","article-title":"Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer\u2019s disease","volume":"42","author":"Alvarez","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.inpsyc.2025.100181_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jtho.2021.01.1616","article-title":"Biomarker discovery and validation: statistical considerations","volume":"16","author":"Ou","year":"2021","journal-title":"J Thorac Oncol"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225004193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225004193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:36:11Z","timestamp":1781782571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610225004193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"alternative-id":["S1041610225004193"],"URL":"https:\/\/doi.org\/10.1016\/j.inpsyc.2025.100181","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.inpsyc.2025.100181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Psychogeriatric Association.","name":"copyright","label":"Copyright"}],"article-number":"100181"}}